UnknownNCT02167048
Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
Medication studyAges 6–18Canada
Understand this study
Who could participate?
Listed age limits: 6 years to 18 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJune 2014
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 52
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 6 Years to 18 Years
- Official registry ID
- NCT02167048
- Official title
Show the full official title
Effects of Low-dose Versus Normal-dose Psychostimulants on Executive Functions in Individuals With Attention-Deficit Hyperactivity Disorder
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Psychostimulants.
Who can participate?
Listed age limits: 6 years to 18 years.
